U.S. Healthcare Services Stock News

MarketAxess Holdings Inc. recently launched TraX Tape, a bond market data solution that consolidates global trading activity into a single standardized feed enriched with real-time analytics and AI-powered pricing intelligence. By layering proprietary data cleansing, directional indicators, yield and spread calculations, and its CP+ pricing engine onto TraX Tape, MarketAxess is aiming to deliver cleaner fixed income data that could make electronic trading workflows more efficient for...

Solid Biosciences (SLDB) has just been added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices, an index reshuffle that can influence how some investors view the stock. See our latest analysis for Solid Biosciences. These index additions come after a strong run in Solid Biosciences' share price, with a 30 day share price return of 66.42% and a year to date share price return of 104.59%. The 1 year total shareholder return of 112.79%...

Iran’s renewed push to impose transit tolls in the Strait of Hormuz has reshaped key shipping routes, and Frontline (NYSE:FRO) is at the center of that shift after reporting earnings tied to longer tanker journeys. See our latest analysis for Frontline. At a share price of $37.66, Frontline’s recent momentum is clear, with a 1-day share price return of 2.14%, a 7-day share price return of 8.25%, and an 82.99% year-to-date share price return. The 1-year total shareholder return of 127.34% and...

NIP Group (NIPG) is set for a 1-for-30.00003 stock split or significant stock dividend on July 6, 2026, shortly after the resignation of Director and Financial Director Ms. Yanjun Xu. See our latest analysis for NIP Group. At a latest share price of $7.79, NIP Group has seen its 30 day share price return fall 33.11% and its 1 year total shareholder return decline 87.58%. This suggests momentum has weakened ahead of the announced stock split and recent board change. If this kind of volatility...

Avalo Therapeutics was recently added to multiple Russell indices and appointed veteran biopharma executive Ron Philip to its board, moves that follow positive Phase 2 data for its lead IL‑1β antibody abdakibart in hidradenitis suppurativa and preparation for investor meetings at the Leerink Partners Therapeutics Forum. Together, the index inclusions, strengthened governance, and focus on IL‑1β‑targeted therapies highlight how a once‑smaller biotech is gaining broader institutional...

Dish Wireless has filed for Chapter 11 bankruptcy, reducing a direct rival in the U.S. wireless market. T-Mobile US plans to shut down its legacy 2G GSM network after 35 years of operation. These developments could affect T-Mobile's pricing power, customer mix, and network modernization timeline. T-Mobile US (NasdaqGS:TMUS) is seeing its competitive position reshaped just as its stock trades at $181.79. The company has posted a gain of 4.5% over the past week and 2.1% over the past month,...

La-Z-Boy stock has delivered a 43.7% return over the past three years, yet current valuation work suggests the shares may still trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach. Over the last three years, La-Z-Boy has returned 43.7%, which puts recent share performance firmly in positive territory but not at levels that clearly rule out further upside if the valuation case holds. For La-Z-Boy, the ability to keep converting earnings into steady cash flow...

Tariffs back in the headlines can rattle import heavy retailers, but they can also shine a light on companies that look better prepared for higher trade frictions. With potential 10% to 12.5% duties on goods from 60 countries and renewed global tariffs on the table, some large U.S. consumer retailers with strong North American focus and healthier balance sheets may be positioned to handle higher costs more effectively than peers. This article walks through 3 stocks from a U.S. Import...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In such an environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on future growth prospects.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings projected to grow by 18% annually in the coming years. In this environment, identifying growth companies with strong insider ownership can be a strategic approach as it often indicates confidence from those closest to the business and potential alignment with shareholder interests.

In the last week, the United States market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. Investing in penny stocks—though often considered a niche area—can still present growth opportunities, especially when these stocks are supported by strong financial health. Here, we explore several intriguing penny stocks that stand out for their financial strength and potential for long-term growth.

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals (NasdaqGS:CRNX) in an all cash deal valued at about US$10b. The boards of both companies approved the transaction unanimously. The deal is expected to close in Q3 2026, subject to regulatory and Crinetics shareholder approvals. Crinetics Pharmaceuticals focuses on endocrine diseases, an area where larger drug makers have been looking to expand their presence. Vertex is set to add Crinetics' pipeline and clinical expertise to...

In late June 2026, Core & Main, Inc. (NYSE:CNM) was removed from multiple Russell growth benchmarks, including the Russell 1000 Growth, 3000E Growth, 2500 Growth, Midcap Growth, and Small Cap Comp Growth indices. This broad index removal could reshape the company’s investor base and trading patterns as funds tracking these benchmarks adjust their Core & Main holdings. We’ll now explore how Core & Main’s removal from several Russell growth indices may affect its previously outlined investment...

MillerKnoll, Inc. recently reported past fourth-quarter and full-year 2026 results showing higher sales of US$1,004.2 million and US$3.84 billion respectively, alongside a move from losses to net income and positive earnings per share from continuing operations. The company also issued fiscal 2027 guidance calling for US$928 million–US$968 million in first-quarter sales and US$3.93 billion–US$4.13 billion for the full year, signaling expectations for higher revenue with gross margins...

With grocery and gas bills squeezing household budgets, consumer staples stocks are sitting at the center of a crucial affordability story. High inflation at 4.2%, wage pressure, and weakening confidence from 57% of Americans who see the economy as worsening are reshaping how and where people spend. That creates different types of risks and potential opportunities across food, beverage, and household product companies. This article walks through 3 stocks from our Consumer Staples screener...

When a major lender like HSBC pulls back from riskier private credit, it sends a clear signal about how banks are thinking about risk, capital and funding costs. For you as an investor, that shift can affect where the steadier opportunities and pressure points show up across large, established financial stocks. This article looks at how tightening underwriting standards and rising regulatory attention around private credit might filter through to more conservative banking stocks. It will walk...

Churchill Capital Corp XI (CCXI) drew fresh attention after outlining a new unsecured promissory note of up to US$1,500,000, convertible into units at US$10.00. This adds another layer to its pending Agility Robotics merger. See our latest analysis for Churchill Capital Corp XI. The Agility Robotics deal and the new convertible note come on the heels of a sharp shift in market sentiment, with Churchill Capital Corp XI’s 30 day share price return of 67.35% and year to date share price return...

The latest ISM Services Index reading points to a US services sector that is still expanding, but with signs of cooling demand and shifting cost pressures. For investors, that mix of steady growth, moderating activity, and cooler input costs can change how certain service stocks look on a risk and reward basis. This article unpacks what that backdrop might mean for companies in our US Services Sector Stocks screener and highlights 3 stocks that appear positively exposed to these conditions,...

Cooling Dutch inflation, with June consumer prices up 2.9% year on year and the HICP reading at 2.5%, is putting fresh attention on interest rate expectations and on sectors that tend to react when borrowing costs move. If the European Central Bank leans more dovish, funding conditions and asset valuations across Financials and Real Estate could shift in ways that matter for your portfolio. This article highlights 3 large, financially solid stocks from our Interest Rate Sensitive Sectors...

Potential Greenpro Capital Corp. ( NASDAQ:GRNQ ) shareholders may wish to note that the President, Chong Kuang Lee...

We wouldn't blame Clover Health Investments, Corp. ( NASDAQ:CLOV ) shareholders if they were a little worried about the...

In the last week, the United States market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In this context, identifying stocks that may be undervalued can provide opportunities for investors seeking to capitalize on potential growth while considering current market conditions.

With the business potentially at an important milestone, we thought we'd take a closer look at Arq, Inc.'s ( NASDAQ:ARQ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...